AddLife AB (publ) (LON:0REZ)

Market Cap	1.50B
Revenue (ttm)	742.38M
Net Income (ttm)	18.19M
Shares Out	n/a
EPS (ttm)	0.15
PE Ratio	82.43
Forward PE	n/a
Dividend	0.04 (0.02%)
Ex-Dividend Date	May 9, 2025

Volume	4,013
Average Volume	7,087
Open	152.95
Previous Close	153.50
Day's Range	152.57 - 154.70
52-Week Range	54.85 - 154.70
Beta	1.59
RSI	59.03
Earnings Date	Apr 4, 2025

About AddLife AB

AddLife AB (publ), together with its subsidiaries, provides equipment, consumables, and reagents primarily to healthcare sector, research, colleges, and universities, as well as the food and pharmaceutical industries. The company operates through Labtech and Medtech segments. The Labtech segment offers products, solutions, and services in the areas of diagnostics, and biomedical research and laboratory analysis equipment. It offers products and solutions, including instruments and equipment, plastic consumables, cell biology, reagents, general ...

• Industry: Medical - Pharmaceuticals
• Sector: Healthcare
• Founded: 1906
• Employees: 2,181
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0REZ

Financial Performance

In 2024, AddLife AB's revenue was 10.29 billion, an increase of 6.21% compared to the previous year's 9.69 billion. Earnings were 252.00 million, an increase of 32.63%.

Financial numbers in SEK